Blood Biomarkers of Uveal Melanoma: Current Perspectives

Código QR

Blood Biomarkers of Uveal Melanoma: Current Perspectives

Manuel F Bande Rodríguez, 1, 2 Beatriz Fernandez Marta, 1 Nerea Lago Baameiro, 3 Maria Santiago-Varela, 1, 2 Paula Silva-Rodríguez, 2, 4 María Jose Blanco-Teijeiro, 1, 2 Maria Pardo Perez, 3 Antonio Piñeiro Ces 1, 2 1Unidad de Retina Quirúrgica...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bande Rodríguez MF, Fernandez Marta B, Lago Baameiro N, Santiago-Varela M, Silva-Rodríguez P, Blanco-Teijeiro MJ, Pardo Perez M, Piñeiro Ces A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	serum biomarker uveal melanoma ophthalmology Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/51643df015ed40b9bd1349836152e92b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Posterior uveal melanoma in adolescents and children: current perspectives
por: Fry MV, et al.
Publicado: (2018)

Uveal melanoma: epidemiology, etiology, and treatment of primary disease
por: Krantz BA, et al.
Publicado: (2017)

Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012)
por: Mahendraraj K, et al.
Publicado: (2016)

The Economic Value of MR-Imaging for Uveal Melanoma
por: Grech Fonk L, et al.
Publicado: (2020)

Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Rino S. Seedor, et al.
Publicado: (2021)

Early experiences of planning stereotactic radiosurgery using 3D printed models of eyes with uveal melanomas
por: Furdová A, et al.
Publicado: (2017)

AMBRA1 attenuates the proliferation of uveal melanoma cells
por: Zhao Binbin, et al.
Publicado: (2021)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Jan Pals, et al.
Publicado: (2021)

Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973–2012)
por: Mahendraraj K, et al.
Publicado: (2017)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Mizue Terai, et al.
Publicado: (2021)

Optical coherence tomography angiography in choroidal melanoma and nevus
por: Ghassemi F, et al.
Publicado: (2018)

Screening for Predictive Parameters Requiring Psycho-Oncological Intervention via the National Comprehensive Cancer Network Distress Thermometer in the Follow-Up of Uveal Melanoma Patients
por: Klingenstein A, et al.
Publicado: (2020)

SUBPOPULATION COMPOSITION OF PERIPHERAL BLOOD LYMPHOCYTES IN UVEAL MELANOMA
por: Svetlana Vladimirovna Saakyan, et al.
Publicado: (2019)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington BY, et al.
Publicado: (2018)

Uveal Melanoma Metastasis
por: Ernesto Rossi, et al.
Publicado: (2021)

Radiological Patterns of Uveal Melanoma Liver Metastases in Correlation to Genetic Status
por: Serdar Yavuzyigitoglu, et al.
Publicado: (2021)

PECULIARITIES OF EFFECTOR LYMPHOCYTES SUBPOPULATIONS IN PATIENTS WITH UVEAL MELANOMA DURING ACTIVATION AND CHRONIC PROGRESS OF HERPESVIRAL INFECTION
por: N. Balatskaya, et al.
Publicado: (2019)

Uveal metastases in the mid-southeastern United States: a single-institution experience
por: King BA, et al.
Publicado: (2018)

Construction and Validation of a Novel Pyroptosis-Related Gene Signature to Predict the Prognosis of Uveal Melanoma
por: Yuan Cao, et al.
Publicado: (2021)

Anticancer effects of mifepristone on human uveal melanoma cells
por: Prisca Bustamante Alvarez, et al.
Publicado: (2021)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Ryota Tanaka, et al.
Publicado: (2021)

Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain
por: Laura Tabuenca Del Barrio, et al.
Publicado: (2021)

No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter
por: Shiva Sabazade, et al.
Publicado: (2021)

Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes
por: Han Zhao, et al.
Publicado: (2021)

Current and emerging treatment options for uveal melanoma
por: Pereira PR, et al.
Publicado: (2013)

A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma
por: Alexander N. Shoushtari, et al.
Publicado: (2021)

Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
por: Xin Hua, et al.
Publicado: (2021)

Detecting Progression of Treated Choroidal Melanomas: Is Ultrasonography Necessary?
por: Guy S. Negretti, et al.
Publicado: (2021)

Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses
por: Aaberg Jr TM, et al.
Publicado: (2014)

Recurrence of Pancreatic Cancer Presenting as Choroidal Metastasis: A Case Report
por: Ebony Smith, et al.
Publicado: (2021)

Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland
por: Samir Aziz, et al.
Publicado: (2008)

Expression of VEGF in human conjunctival melanoma analyzed with immunohistochemistry
por: Kase S, et al.
Publicado: (2018)

Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights
por: Mor JM, et al.
Publicado: (2019)

Guanine nucleotide exchange factor H1 can be a new biomarker of melanoma
por: Shi J, et al.
Publicado: (2016)

Serum proteins and lipids in mild form of calf bronchopneumonia: candidates for reliable biomarkers
por: Kovačić Marijana, et al.
Publicado: (2017)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi M, et al.
Publicado: (2013)

Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
por: Shah NV, et al.
Publicado: (2013)

Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome
por: Pautler SE, et al.
Publicado: (2014)

Serum TSLP is a potential biomarker of psoriasis vulgaris activity
por: El-Ghareeb MI, et al.
Publicado: (2019)

Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah NV, et al.
Publicado: (2012)